Sunesis Pharmaceuticals beats by $0.06, beats on revenue

|About: Sunesis Pharmaceuticals, Inc. (SNSS)|By:, SA News Editor

Sunesis Pharmaceuticals (NASDAQ:SNSS): Q1 EPS of -$0.21 beats by $0.06.

Revenue of $0.24M (-64.2% Y/Y) beats by $0.04M.

Press Release

Subscribe for full text news in your inbox